On May 16th the Committee on Criminal and Criminal Procedural Law of the Bar Association of Ukraine held a session to discuss application of Law No. 7275 “On Amending Some Legislative Acts on Observance of Human Rights of Criminal Proceedings Participants and Other Persons by Law Enforcement Agencies at Pre-Trial Investigation”, which is also known as “Mask-show stop”.
The event, which was attended by representatives of judicial authorities and attorneys of leading law firms, discussed such issues as history and problems of last amendments to the Criminal Procedure Code, novelties of the Code and current practice of the amendments application.
Legal Alliance Company was represented by counsel and attorney Taras Bezpalyy, who pointed the possibility of abolishing the notice of suspicion.
“The lawmaker entitled the defendant to challenge the notice of suspicion, however advocates, besides practicing, should decide at which stage they should challenge the notice of suspicion, since in case of its abolishment by the ruling of an investigative judge, the investigator has the right to issue the suspicion again with corrections, which will not be good for the client at the pre-trial investigation stage”, said Mr Bezpalyy.
Contact the author: Taras Bezpalyy, counsel at Legal Alliance Company, bezpalyy@l-a.com.ua
The event focused on the transformation of Ukraine's intellectual property sector on its path toward European integration.
Improving access to safe and affordable medicines for the Ukrainian population is one of the Government of Ukraine's top priorities. SAFEMed Activity (2017-2025) has supported this effort by appIying health system strengthening best practices.
The Ministry of Health website has posted a notice about the release of a revised draft order of the Ministry of Health ‘On Approval of Amendments to Certain Re
On 25 September, a webinar was held on the topic: ‘180 days of new drug price regulation. Results, prospects and practical advice.’ The event was organized by LA Law Firm in partnership with Proxima Research International.
